1 The abilities of muscarinic agonists (arecoline, bethanechol, carbachol, methacholine, pilocarpine) to inhibit isoprenaline-induced cyclic AMP production in chopped fragments (via M 2 receptors), and to evoke cationic current (I cat ) (via M 2 receptors) or calcium store release (via M3 receptors) in enzyme-dispersed, single voltage-clamped cells from longitudinal smooth muscle of the guinea-pig small intestine were examined. 2 All muscarinic agonists (1 ± 300 mM) examined inhibited isoprenaline (1 mM)-induced accumulation of cyclic AMP, the IC 50 varying from 52 to 248 mM. However, their relative potencies to evoke this M 2 eect were not signi®cantly correlated with their ability to evoke I cat , also a M 2 eect, whether or not calcium stores were depleted; pilocarpine and McN-A343 inhibited the I cat response to carbachol. 3 Muscarinic agonists (concentration 300 or 1000 mM), except pilocarpine and McN-A343 which were ineective, evoked Ca 2+ -activated K + current (I K-Ca ) resulting from Ca 2+ store release (M 3 eect). Their eectiveness was tested by estimating residual stored calcium by subsequent application of caeine (10 mM). The relative potencies to evoke Ca 2+ store release (M 3 ) and for I cat activation (M 2 ) were closely correlated (P50.001). 4 These data might be explained if M 2 -mediated adenylyl cyclase inhibition and I cat activation involve dierent G proteins, or involve dierent populations of M 2 receptors. The observed correlation of agonist potency between I cat activation and Ca 2+ store release supports the proposal (Zholos & Bolton, 1997) that M 3 activation can potentiate M 2 -cationic channel coupling through Ca 2+ -independent mechanisms.